ArticleHeliyon2024

Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response.

Peng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.